Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

LifeTech Scientific to Market Broncus' Pulmonary Medical Devices in China

publication date: Oct 22, 2012
LifeTech Scientific, previously known as a China maker of cardiovascular medical devices, has joined with Broncus Technologies of the US to form a partnership that will commercialize Broncus’ LungPoint® Navigation System in China. The system enables physicians to plan bronchoscopic procedures, and then navigate to precise locations in the lungs to diagnose and treat lung cancers. The partnership is also being joined by DiNova Venture Partners of Shanghai and Themes Investment Partners of Hong Kong. Last week, Medtronic announced that it would pay $66 million to acquire a 26% stake in LifeTech. More details....

Stock Symbols: (HK: 8122) (NYSE: MDT)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China